|
|
| Week of Expected Pricing |
Withdrawn |
| Company Name |
COLE HAAN INC |
| Proposed Ticker |
N/A |
| CUSIP |
N/A |
| Business Description |
inherited genetic disorders of hemoglobin, known as hemoglobinopathies. Our |
| Lead Underwriter |
BofA Securities, Inc, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC |
| Co-Managers |
Cowen and Company, LLC, Jefferies LLC, Piper Sandler & Co, Robert W. Baird & Co. Incorporated,Stifel Nicolaus & Company, Incorporated |
| Initial Shares |
N/A |
| Revised Initial Shares |
N/A |
| Initial Price |
N/A |
| Revised Price |
N/A |
| Final Price |
N/A |
| Final Ticker |
N/A |
|
|
|
|
